Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
PSA Doubling Time Calculator
Summary of PSA Doubling Time and Velocity Definitions | Download Table
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Roundtable Discussion: Morgans Addresses How PSA Levels Affect Nonmetastatic CRPC Treatment
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Proposal for a Standardized PSA Doubling-time Calculation
Prostatic Specific Antigen for Prostate Cancer Detection
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - The Lancet Oncology
Day 3,508 – PSA Results | Dan's Journey through Prostate Cancer
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Long-Term Outcomes After High-Dose Postprostatectomy Salvage Radiation Treatment - International Journal of Radiation Oncology, Biology, Physics
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Cureus | Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time | American Society of Clinical Oncology Educational Book
Abiraterone Acetate for Adenocarcinoma Clinical Trial 2022 | Power
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - ScienceDirect
